<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 20 May 2026 03:49:35 -0400--><rss version="2.0">
    <channel>
        <title>bioAffinity Technologies, Inc. (BIAF) Press Releases</title>
        <link>https://ir.bioaffinitytech.com/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://s3.amazonaws.com/equisolve-dev4/bioaffinitytech/files/theme/images/logo-sm.png</url>
                <title>bioAffinity Technologies, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/181/bioaffinity-technologies-reports-record-monthly-cypath-lung-unit-sales-and-significant-year-over-year-growth-in-april-2026</link>
                <pubDate>Tue, 12 May 26 09:15:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/181/bioaffinity-technologies-reports-record-monthly-cypath-lung-unit-sales-and-significant-year-over-year-growth-in-april-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/180/bioaffinity-technologies-reports-first-quarter-2026-results-and-expanding-adoption-and-clinical-usage-of-cypath-lung</link>
                <pubDate>Fri, 08 May 26 08:30:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/180/bioaffinity-technologies-reports-first-quarter-2026-results-and-expanding-adoption-and-clinical-usage-of-cypath-lung</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/179/bioaffinity-technologies-launches-new-study-to-expand-use-of-cypath-lung-technology-for-asthma-and-copd-diagnosis-and-treatment</link>
                <pubDate>Tue, 28 Apr 26 09:16:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/179/bioaffinity-technologies-launches-new-study-to-expand-use-of-cypath-lung-technology-for-asthma-and-copd-diagnosis-and-treatment</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/178/new-case-study-bioaffinity-technologies-cypath-lung-diagnostic-supports-physicians-assessment-prompts-follow-up-imaging-and-defers-unnecessary-biopsy</link>
                <pubDate>Tue, 14 Apr 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/178/new-case-study-bioaffinity-technologies-cypath-lung-diagnostic-supports-physicians-assessment-prompts-follow-up-imaging-and-defers-unnecessary-biopsy</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/177/bioaffinity-technologies-cypath-lung-to-be-featured-at-cleveland-clinic-annual-advances-in-early-lung-cancer-detection-symposium-april-16</link>
                <pubDate>Tue, 07 Apr 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/177/bioaffinity-technologies-cypath-lung-to-be-featured-at-cleveland-clinic-annual-advances-in-early-lung-cancer-detection-symposium-april-16</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/176/bioaffinity-technologies-cypath-lung-test-unit-sales-surged-146-year-over-year-in-q1-2026</link>
                <pubDate>Wed, 01 Apr 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/176/bioaffinity-technologies-cypath-lung-test-unit-sales-surged-146-year-over-year-in-q1-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/175/bioaffinity-technologies-to-host-live-virtual-physician-roundtable-on-integrating-cypath-lung-into-pulmonary-practice</link>
                <pubDate>Wed, 25 Mar 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/175/bioaffinity-technologies-to-host-live-virtual-physician-roundtable-on-integrating-cypath-lung-into-pulmonary-practice</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/174/new-case-study-bioaffinity-technologies-cypath-lung-provides-actionable-results-and-helps-patient-avoid-costly-invasive-procedures</link>
                <pubDate>Tue, 17 Mar 26 07:45:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/174/new-case-study-bioaffinity-technologies-cypath-lung-provides-actionable-results-and-helps-patient-avoid-costly-invasive-procedures</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/173/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagnostic-cypath-lung</link>
                <pubDate>Fri, 13 Mar 26 08:00:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/173/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagnostic-cypath-lung</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.bioaffinitytech.com/news-events/press-releases/detail/172/bioaffinity-technologies-announces-initiation-of-large-scale-longitudinal-clinical-study-for-its-noninvasive-cypath-lung-cancer-diagnostic</link>
                <pubDate>Tue, 10 Mar 26 07:47:00 -0400</pubDate>
                <guid>https://ir.bioaffinitytech.com/news-events/press-releases/detail/172/bioaffinity-technologies-announces-initiation-of-large-scale-longitudinal-clinical-study-for-its-noninvasive-cypath-lung-cancer-diagnostic</guid>
                                                                            </item>
            </channel>
</rss>